Status:
COMPLETED
Crystalloid FLUID Choices for Resuscitation of Hospitalized Patients
Lead Sponsor:
Ottawa Hospital Research Institute
Conditions:
Fluid Therapy
Eligibility:
All Genders
29+ years
Phase:
PHASE4
Brief Summary
The aim of the FLUID Trial is to conduct a pragmatic, multi-centre, open label randomized cluster cross-over trial (RCT) to determine whether fluid administration with 0.9% saline as compared to Ringe...
Detailed Description
Crystalloid fluids are used extensively for acutely ill patients who are admitted to hospital. Two fluids most commonly used are 0.9% saline and Ringer's Lactate. Both are used to rehydrate patients, ...
Eligibility Criteria
Inclusion
- ● All adult and pediatric patients with an index admission to the participating hospitals during study periods
Exclusion
- neonates
- physicians may opt out of the use of the allocated study fluid for a specific patient
Key Trial Info
Start Date :
August 15 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 13 2020
Estimated Enrollment :
43626 Patients enrolled
Trial Details
Trial ID
NCT04512950
Start Date
August 15 2016
End Date
June 13 2020
Last Update
May 2 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton General Hospital
Hamilton, Ontario, Canada, L8L 2X2
2
University Hospital
London, Ontario, Canada, N6A 5A5
3
Victoria Hospital
London, Ontario, Canada, N6A 5W9
4
Montfort Hospital
Ottawa, Ontario, Canada, K1K 0T2